MENU
MGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MacroGenics (MGNX) Ownership - Who owns MacroGenics?
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
339
Web
https://www.macrogenics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
82.96M
P/E Ratio
N/A
Total Cash
154.14M
Projected Growth
N/A
Total Debt
37.47M
Revenue
152.43M
Risk (Beta)
1.37
Dividend Yield
N/A
Total Cash/Share
2.44
Total Debt/Equity
N/A
Revenue/Share
2.43 USD as % of share price
Fundamentals
MGNX
Capitalization
83M
P/E Ratio
N/A
Risk (Beta)
1.37
Dividend Yield
N/A
Total Cash
154M
Total Cash/Share
2.44
Total Debt
37.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.43%
Revenue
152M
ROE
N/A
Book Value
79.1M
P/B Ratio
1.05
Cash Flow
N/A
Earnings
-0.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
631K
Current Ratio
3.28
Current Revenue Per Employee
38686.22
Dividends Per Share - Security
N/A
EBITDA
-47.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
59.07
Revenue To Assets
-23.61
Shares Held By Institutions
116M
Shares Outstanding - Current
63.1M
Total Liabilities
145M
Total Volume MTD
N/A
Value
-1
Gain YTD
-59.538
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the discovery and development of monoclonal antibody-based therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
339
Web
https://www.macrogenics.com